Clinical Trials Browser

Phase 3 × Neoplasms × NET × Clear all

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT00171873 2020-03-26

Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut

Phase 3 Completed

85 enrolled 6 charts

EndocrineNET

Disease, Neoplasms, Neuroendocrine Tumors

Clinical Trials

Tumor HI

Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut